Follow the ICON PLC share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €12.8bn. The latest transaction was filed on 12 August 2026 (Levée d'options). Among the most active insiders: Clerkin Nigel Bernard John. The full history is free.
44
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€1m
34 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ICON PLC Buy (bullish), based on 16 analysts. Average price target: US$185.56.
Buys n/a€1m Sells
Fundamental score
Ranked 19,638 of 28,588 companies
39.4
score / 100
Value
47
Quality
32
FCF yld6.8%
Earn yld1.8%
EV/EBITDA19.6x
ROE0.3%
Gross mgn26%
Net mgn2.8%
Debt/EBITDA4.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ICON PLC is a clinical research organization that provides services to the pharmaceutical and biopharmaceutical industries. It specializes in drug development and the management of clinical trials.